Biolase (BIOL) Doubles This Year: How To Trade After Earnings?

The stock of dental lasers and other biological products company Biolase Inc (NASDAQ: BIOL) has been one of the biggest gainers so far this year.

Over the course of the past three weeks, the stock has made considerable gains and that has taken its gains for the year so far to as high as 100%. On Thursday, the company reported its financial results for the fourth quarter and in light of the Biolase stock’s gains, investors ought to take a look at the performance.

Related:  Sunshine Biopharma (SBFM) Stock Rebounds After The Recent Correction

The company reported a loss of as big as $6.1 million in the quarter, which worked out to losses per share of 7 cents. On the other hand, the dental laser company generated revenues of as much as $8.5 million for the quarter. However, for the full year, Biolase’s losses actually went down to $16.8 million. The revenues for the full year came in at $22.8 million. In the quarter that is going to end in April, the company expects to generate revenues in the range between $7.5 million and $8 million.

Asan Abdiev

CEO and Editor in Chief. Living in the era of dynamic tech change Asan decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring Finance) writing for technology and as well as finance has been one of the precious aspects of his life